Literature DB >> 9523596

Activation of p38MAPK in microglia after ischemia.

K M Walton1, R DiRocco, B A Bartlett, E Koury, V R Marcy, B Jarvis, E M Schaefer, R V Bhat.   

Abstract

p38MAPK has been implicated in the regulation of proinflammatory cytokines and apoptosis in vitro. To understand its role in neurodegeneration, we determined the time course and localization of the dually phosphorylated active form of p38MAPK in hippocampus after global forebrain ischemia. Phosphorylated p38MAPK and mitogen-activated protein kinase-activated protein 2 activity increased over 4 days after ischemia. Phosphorylated p38MAPK immunoreactivity was observed in microglia in regions adjacent to, but not in, the dying CA1 neurons. In contrast, neither c-Jun N-terminal kinase 1 nor p42/p44MAPK activity was altered after ischemia. These results provide the first evidence for localization of activated p38MAPK in the CNS and support a role for p38MAPK in the microglial response to stress.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9523596     DOI: 10.1046/j.1471-4159.1998.70041764.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  32 in total

Review 1.  Microglial activation in stroke: therapeutic targets.

Authors:  Midori A Yenari; Tiina M Kauppinen; Raymond A Swanson
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

2.  Rosmarinic Acid Mitigates Lipopolysaccharide-Induced Neuroinflammatory Responses through the Inhibition of TLR4 and CD14 Expression and NF-κB and NLRP3 Inflammasome Activation.

Authors:  Yicong Wei; Jianxiong Chen; Yonghong Hu; Wei Lu; Xiaoqin Zhang; Ruiguo Wang; Kedan Chu
Journal:  Inflammation       Date:  2018-03       Impact factor: 4.092

Review 3.  The inflammatory response in stroke.

Authors:  Qing Wang; Xian Nan Tang; Midori A Yenari
Journal:  J Neuroimmunol       Date:  2006-12-26       Impact factor: 3.478

Review 4.  Inflammatory responses in brain ischemia.

Authors:  Masahito Kawabori; Midori A Yenari
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

5.  p53-induced uncoupling expression of aquaporin-4 and inwardly rectifying K+ 4.1 channels in cytotoxic edema after subarachnoid hemorrhage.

Authors:  Jun-hao Yan; Nikan H Khatibi; Hong-bin Han; Qin Hu; Chun-hua Chen; Li Li; Xiao-mei Yang; Chang-man Zhou
Journal:  CNS Neurosci Ther       Date:  2012-03-15       Impact factor: 5.243

6.  Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia.

Authors:  T Tikka; B L Fiebich; G Goldsteins; R Keinanen; J Koistinaho
Journal:  J Neurosci       Date:  2001-04-15       Impact factor: 6.167

7.  (-)-Epigallocatechin-3-gallate increases the number of neural stem cells around the damaged area after rat traumatic brain injury.

Authors:  Tatsuki Itoh; Motohiro Imano; Shozo Nishida; Masahiro Tsubaki; Nobuyuki Mizuguchi; Shigeo Hashimoto; Akihiko Ito; Takao Satou
Journal:  J Neural Transm (Vienna)       Date:  2012-01-04       Impact factor: 3.575

8.  The roles of p38 MAPK/MSK1 signaling pathway in the neuroprotection of hypoxic postconditioning against transient global cerebral ischemia in adult rats.

Authors:  Pingping Zhu; Lixuan Zhan; Tingna Zhu; Donghai Liang; Jiaoyue Hu; Weiwen Sun; Qinghua Hou; Huarong Zhou; Baoxing Wu; Yanmei Wang; En Xu
Journal:  Mol Neurobiol       Date:  2013-12-19       Impact factor: 5.590

9.  Neuroprotective effects of total steroid saponins on cerebral ischemia injuries in an animal model of focal ischemia/reperfusion.

Authors:  Xinxin Zhang; Lin Chen; Xuan Dang; Jianli Liu; Yoichiro Ito; Wenji Sun
Journal:  Planta Med       Date:  2014-06-25       Impact factor: 3.352

10.  Edaravone protects against apoptotic neuronal cell death and improves cerebral function after traumatic brain injury in rats.

Authors:  Tatsuki Itoh; Takao Satou; Shozo Nishida; Masahiro Tsubaki; Motohiro Imano; Shigeo Hashimoto; Hiroyuki Ito
Journal:  Neurochem Res       Date:  2009-09-19       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.